Telaprevir in the Treatment of Acute HCV Infection in HIV-infected Men
暂无分享,去创建一个
A. Branch | D. Dieterich | D. Fierer | A. Uriel | M. Mullen | D. Carriero | R. M. Hijdra | David Cassagnol | W. V. Seggelen
[1] M. Hellard,et al. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals , 2013, Hepatology.
[2] V. Soriano,et al. Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV , 2013, Annals of Internal Medicine.
[3] M. Manns,et al. Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial. , 2013, The Lancet. Infectious diseases.
[4] L. Taylor,et al. Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] V. Martel-Laferrière,et al. Septic bursitis, a potential complication of protease inhibitor use in hepatitis C virus. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] V. Miller,et al. Closing in on the target: sustained virologic response in hepatitis C virus genotype 1 infection response-guided therapy. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] A. Branch,et al. Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] D. Webster,et al. Spontaneous clearance and treatment of acute hepatitis C infection in HIV-positive men with 48 weeks of interferon-alpha and Ribavirin , 2013, International journal of STD & AIDS.
[9] V. Miller,et al. Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents , 2012, Hepatology.
[10] A. Branch,et al. Early-onset liver fibrosis due to primary hepatitis C virus infection is higher over time in HIV-infected men. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] J. Kaldor,et al. Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection , 2012, AIDS.
[12] L. Naeger,et al. Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment , 2012, Hepatology.
[13] C. Datz,et al. Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection. , 2012, Gastroenterology.
[14] Michael Adler,et al. Response-guided telaprevir combination treatment for hepatitis C virus infection. , 2011, The New England journal of medicine.
[15] E. Schiff,et al. Hepatitis C virus infection in USA: an estimate of true prevalence , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[16] J. V. D. van der Meer,et al. Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration , 2011, AIDS.
[17] R. Bruno,et al. Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C. , 2011, The Journal of infectious diseases.
[18] C. Cordes,et al. Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): The "Real-life Setting" proves the concept , 2011 .
[19] Joseph Eliahoo,et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men , 2010, Gut.
[20] S. Pol,et al. Treatment of acute hepatitis C in human immunodeficiency virus–infected patients: The HEPAIG study , 2010, Hepatology.
[21] E. Bottieau,et al. Surveillance and outbreak reports Hepatitis C virus infection in HIV-infected men who have sex with men : sustained rising incidence in Antwerp , Belgium , 2001 – 2009 , 2010 .
[22] E. Vittinghoff,et al. Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco , 2010, PloS one.
[23] A. Samri,et al. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus , 2009, AIDS.
[24] David B. Goldstein,et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.
[25] Jacques Fellay,et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.
[26] G. Everson,et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. , 2009, The New England journal of medicine.
[27] J. Kaldor,et al. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] A. Branch,et al. Rare birds in North America: acute hepatitis C cohorts. , 2009, Gastroenterology.
[29] A. Branch,et al. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. , 2008, The Journal of infectious diseases.
[30] C. Katlama,et al. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients , 2006, AIDS.
[31] C. B. Hare,et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. , 2006, Journal of acquired immune deficiency syndromes.
[32] Michael J. Rausch,et al. Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals. , 2006, Antiviral therapy.
[33] B. Gazzard,et al. Transmission of Hepatitis C Virus Among HIV-Positive Homosexual Men and Response to a 24-Week Course of Pegylated Interferon and Ribavirin , 2005, Journal of acquired immune deficiency syndromes.
[34] J. Montaner,et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. , 2004, The New England journal of medicine.
[35] P. Volberding,et al. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. , 2004, The New England journal of medicine.
[36] Dieter Häussinger,et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.
[37] C. Trautwein,et al. Treatment of acute hepatitis C with interferon alfa-2b. , 2001, The New England journal of medicine.